Vastox Buys Two Firms

U.K. biotech firm Vastox has acquired DanioLabs, a private U.K. drug discovery company, and Dextra Laboratories, a carbohydrate chemistry service company. According to Vastox, the DanioLabs buy, for $30 million, adds two clinical and two preclinical programs in neurological and ophthalmic diseases. The Dextra acquisition, for $3 million, will enhance Vastox' capabilities in carbohydrate chemistry.